PD-L1 upregulation by lytic induction of Epstein-Barr Virus - ScienceDirect

Por um escritor misterioso

Last updated 06 abril 2025

PD-L1 upregulation by lytic induction of Epstein-Barr Virus - ScienceDirect

Role of the Epstein–Barr virus-encoded latent membrane protein-1, LMP1, in the pathogenesis of nasopharyngeal carcinoma

Update on Kaposi's sarcoma and other HHV8 associated diseases. Part 2: pathogenesis, Castleman's disease, and pleural effusion lymphoma - The Lancet Infectious Diseases

Latency and lytic replication in Epstein–Barr virus-associated oncogenesis

Epstein‒Barr virus–associated cellular immunotherapy - Cytotherapy

Joining Forces: Improving Clinical Response to Cellular Immunotherapies with Small-Molecule Inhibitors: Trends in Molecular Medicine

Long-term antiretroviral therapy initiated in acute HIV infection prevents residual dysfunction of HIV-specific CD8+ T cells - eBioMedicine

Cancers, Free Full-Text

Identification of distinct subgroups of EBV-positive post-transplant diffuse large B-cell lymphoma - Modern Pathology

Advancing therapeutic strategies for Epstein-Barr virus-associated malignancies through lytic reactivation - ScienceDirect

Tumorigenesis and diagnostic practice applied in two oncogenic viruses: Epstein Barr virus and T-cell lymphotropic virus-1—Mini review - ScienceDirect